Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options (Q42986593)

From Wikidata
Jump to navigation Jump to search
scientific article published on 23 November 2012
edit
Language Label Description Also known as
English
Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options
scientific article published on 23 November 2012

    Statements

    Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit